Meril Life Sciences, headquartered in Vapi, Gujarat, has introduced the Mizzo Endo 4000, a soft tissue robotic platform engineered for general, urology, gynecology, thoracic, colorectal, bariatric, hepatobiliary, ENT, gastrointestinal, and oncology procedures. Built and designed in India, the system targets precision, access, and cost barriers that have historically limited adoption. It pairs AI-powered 3D anatomical mapping with an open console design and immersive visualization, while enabling remote collaboration and telesurgery over high-performance 5G networks. Strategically, this positions India to compete with incumbent systems from Intuitive Surgical, Medtronic, and CMR Surgical, while appealing to price-sensitive markets across Asia and Africa.